 |
The Journal of Neuroscience, December 6, 2006, 26(49):12748-12757; doi:10.1523/JNEUROSCI.3873-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism
Daniel del Toro,1
Josep M. Canals,1
Silvia Ginés,1
Masami Kojima,2,3
Gustavo Egea,1 and
Jordi Alberch1
1Departament de Biologia Cel·lular i Anatomia Patològica, Facultat de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, 08036 Barcelona, Spain, 2Research Institute for Cell Engineering, National Institute of Advanced Industrial Science and Technology, Ikeda, Osaka 563-8577, Japan, and 3Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama, 332-0012, Japan
Correspondence should be addressed to Dr. Jordi Alberch, Departament de Biologia Cel·lular i Anatomia Patològica, Facultat de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Carrer Casanova 143, E-08036 Barcelona, Spain. Email: alberch{at}ub.edu
Brain-derived neurotrophic factor (BDNF) polymorphism is associated with the pathophysiology of several neurodegenerative disorders, including Huntington's disease. In view of these data and the involvement of huntingtin in intracellular trafficking, we examined the intracellular transport and release of Val66Val BDNF (Val-BDNF) and Val66Met BDNF (Met-BDNF) in transfected striatal knock-in cells expressing wild-type or mutant full-length huntingtin. Colocalization studies with specific markers for endoplasmic reticulum showed no differences between the Val-BDNF and Met-BDNF and were not modified by mutant huntingtin. However, post-Golgi trafficking was altered by mutant huntingtin dependent on the BDNF form. Thus, fluorescence recovery after photobleaching (FRAP) and inverse FRAP analysis showed retention of Met-BDNF in the Golgi apparatus with respect to Val-BDNF in wild-type cells. Strikingly, mutant huntingtin diminished post-Golgi trafficking of Val-BDNF, whereas Met-BDNF was not modified. Accordingly, a reduction in the number of transport vesicles was only observed in mutant huntingtin cells transfected with Val-BDNF but not Met-BDNF. Moreover, mutant huntingtin severely affected the KCl-evoked release of Val-BDNF, although it had little effect on Met-BDNF regulated release. The constitutive release of Val-BDNF or Met-BDNF in mutant cells was only slightly reduced. Interestingly, mutant huntingtin only perturbed post-Golgi trafficking of proteins that follow the regulated secretory pathway (epidermal growth factor receptor or atrial natriuretic factor), whereas it did not change those that follow the constitutive pathway (p75NTR).
We conclude that mutant huntingtin differently affects intracellular transport and release of Val-BDNF and Met-BDNF. In addition, our findings reveal a new role for huntingtin in the regulation of the post-Golgi trafficking of the regulated secretory pathway.
Key words: Huntington's disease; neurotrophin; vesicular transport; trans-Golgi network; p75; EGFR
Received April 20, 2006;
revised Oct. 25, 2006;
accepted Oct. 26, 2006.
Correspondence should be addressed to Dr. Jordi Alberch, Departament de Biologia Cel·lular i Anatomia Patològica, Facultat de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Carrer Casanova 143, E-08036 Barcelona, Spain. Email: alberch{at}ub.edu
This article has been cited by other articles:

|
 |

|
 |
 
R. Smith, K. Bacos, V. Fedele, D. Soulet, H. A. Walz, S. Obermuller, A. Lindqvist, M. Bjorkqvist, P. Klein, P. Onnerfjord, et al.
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion
Hum. Mol. Genet.,
October 15, 2009;
18(20):
3942 - 3954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. del Toro, J. Alberch, F. Lazaro-Dieguez, R. Martin-Ibanez, X. Xifro, G. Egea, and J. M. Canals
Mutant Huntingtin Impairs Post-Golgi Trafficking to Lysosomes by Delocalizing Optineurin/Rab8 Complex from the Golgi Apparatus
Mol. Biol. Cell,
March 1, 2009;
20(5):
1478 - 1492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Seo, W. Kim, and O. Isacson
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients
Hum. Mol. Genet.,
October 15, 2008;
17(20):
3144 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Chou, J.-Y. Weng, H.-L. Lai, F. Liao, S. H. Sun, P.-H. Tu, D. W. Dickson, and Y. Chern
Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes
J. Neurosci.,
March 26, 2008;
28(13):
3277 - 3290.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|